Arrayit Corporation Logo

Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
- Powerful Science for Life™

Investors - Press Releases

Arrayit Corporation provides an archive of company press releases. Please click on the links to read our press releases.

2/10/14 - Arrayit Corporation Showcases High Sensitivity Diagnostic Microarray Technology at 21st International Molecular Medicine Tri-Conference.

1/21/14 - Arrayit Corporation Showcases Advanced Robotic Microarray Technology at Laboratory Automation Conference 2014.

1/16/14 - Arrayit Corporation Participates in the International Plant and Animal Genome Conference XXII; Hosts Technology Workshop Breakthroughs in Microarray Technology.

12/30/13 - Arrayit Corporation Commences Business Operations from New Sunnyvale Headquarters.

11/27/13 - Arrayit Corporation Announces Life Sciences Instrument Sale to Top Research Center in Ontario.

11/22/13 - Arrayit Corporation Announces Microarray Platform Sale to Leading Laboratory in Israel.

11/19/13 - Arrayit Corporation To Work With Diagnostic Oncology Research Organization (DOCRO) To Obtain FDA Approvals.

11/11/13 - Arrayit Corporation Engages Professional Services of Diagnostic Oncology Research Organization.

11/8/13 - Arrayit Corporation To Host Conference Call To Discuss Third Quarter 2013 Results.

10/31/13 - Arrayit Corporation Receives Contract Award from the Department of Veteran Affairs.

10/28/13 - Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California.

10/17/13 - Arrayit appoints Sid Taubenfeld R.Ph to the Board of Directors.

6/26/13 - Arrayit Corporation Signs Exclusive Distributorship Agreement With DHK Medical Products for Genome Testing in India.

11/14/12 - Arrayit Diagnostics Files S-1 Registration Statement.

10/4/12 - Arrayit Diagnostics, Inc. Announces $8 Million Financing Commitment.

4/17/12 - Arrayit Corporation Posts 60% Quarterly Sales Increase.

4/4/12 - Arrayit Diagnostics, Inc. Reports Results of Research Study for Ovarian Cancer Diagnostic Test.

3/21/12 - Arrayit Spokesperson Khrystyne Haje to Appear on Rachael Ray to Support Cancer Patients in Treatment.

2/15/12 - Arrayit Corporation Announces Stock Dividend Distribution Date for Shareholders.

2/2/12 - Arrayit's CEO, Rene Schena, Chosen to Promote Economic Growth Center to Big Pharma and Biotech Businesses.

12/14/11 - Arrayit Corporation to Spin-Off Arrayit Diagnostics, Inc. to Shareholders.

8/3/11 - Arrayit Corporation Reports 47% Revenue Growth.

4/1/11 - Arrayit Corporation Announces the Product Launch of OvaDx(R), the Market's First Pre-Symptomatic Screening Test for Ovarian Cancer.

9/20/10 - Arrayit Corporation Completes Proteomics Platform Installation and Training at the National Institutes of Health.

8/23/10 - Arrayit Corporation Announces Premarket Approval (PMA) Submission Strategy for OvaDx®.

8/15/10 - Arrayit Corporation Adds 128 New Products to Its Life Sciences Tools Portfolio.

7/29/10 Arrayit Corporation Taps Former IVAX Diagnostics Executive to Build Strategic Partnerships.

6/30/10 - Arrayit Corporation Receives Registered Trademark for OvaDx®.

6/16/10 - Arrayit Corporation Technology May Provide Vital Clues to Detoxification of the Oceans.

5/10/10 - Arrayit Corporation Reports Strong Surge in Customer Demand for the Company's Leading Edge Life Sciences Microarray Instruments.

4/20/10 Arrayit Corporation to Present at Southern California Investment Association Summer Capital Conference.

4/15/10 - Arrayit Achieves Significant Progress in First Quarter 2010.

3/22/10 - Arrayit Corporation Taps DOCRO, Inc. to Facilitate FDA Approval of OvaDx.

3/15/10 - Arrayit Corporation Completes Installation of Patented Manufacturing Technology in Russia.

2/24/10 - Arrayit Corporation President Dr. Mark Schena to Appear Live on the Television Program the Big Biz Show.

2/18/10 - Arrayit Corporation Has Discovered a Pathway to True Health Care Reform With Pre-symptomatic Diagnostics.

2/4/10 - Arrayit Wins Landmark DNA Testing Patent in Israel.

1/25/10 - Arrayit Corporation's Proteomic Biomarkers Clear the Way for Pre-Symptomatic Detection of Ovarian Cancer and Other Major Diseases.

1/19/10 Arrayit Corporation Selected by Silicom Ventures to Present at the 2010 Personalized Medicine World Conference in Silicon Valley.

1/7/10 Major News Media Missed the Mark -- There Is a New Pre-Symptomatic Screening Test for Ovarian Cancer Coming From Arrayit Corporation, and It Will Be Available Soon.

12/22/09 - Arrayit Corporation Announces Manufacturing Breakthrough.

12/17/09 - Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010.

12/10/09 - Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation.

12/09/09 - Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics.

11/30/09 - Arrayit Diagnostics Names Elite Financial Communications Group as Investor Relations/Public Relations Counsel.

11/18/09 - Arrayit Technology Purchased by Johns Hopkins University to Study Rheumatoid Arthritis.

11/12/09 - Arrayit Diagnostics Focused on Early Stage Disease Detection.

11/05/09 - Arrayit Corporation to Diagnose Early Stage Cancers and Monitor Effectiveness of Treatments.

11/02/09 - Arrayit Corporation Blood Tests Diagnose Early Stage Cancers and Communicable Diseases.

10/28/09 - Arrayit Announces NanoPrint Sale to Leukemia Center in Poland.

10/22/09 - Arrayit and the USDA Join Forces to Protect America's Crop Plants.

10/15/09 - Will Arrayit Technology Identify Life on Mars?

10/07/09 - Arrayit Corporation CEO Reports to Shareholders.

10/05/09 - Arrayit Deploys Next-Generation Proteomics Platform.

9/28/2009 - Arrayit Wins Contract With Austrian Institute of Technology for Detection of Highly Dangerous Pathogens.

9/21/2009 - Arrayit Wins Equipment Contract From Sandia National Laboratories.

9/16/2009 - Arrayit Wins Manufacturing Contract From the Centers for Disease Control.

9/10/2009 - Arrayit Offers Million Dollar Biomarker Discovery Service.

9/02/2009 - Arrayit Lands Patent for Population Scale Diagnostics in World's Most Populous Country.

8/27/2009 - Arrayit Speeds Allergy Testing.

8/12/2009 - Arrayit Corporation Opens International Marketing Headquarters in Houston.

7/23/2009 - Arrayit Corporation Announces Worldwide Product Sales Up Nearly 50%.

7/16/2009 - Arrayit Corporation and Parkinson's Institute Implement New Screening Techniques for Identification of Molecular Biomarkers.

6/24/2009 - Mark Schena, PhD, Positions Arrayit Corporation to Enter Molecular Diagnostics Using VIP Technology.

6/18/2009 - Arrayit Corporation Addresses Flu Pandemic - Breakthrough Technology Provides Population-Wide Screening.

4/30/2009 - Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip.

4/21/2009 - Arrayit Speeds Analysis of the Human Genome.

4/07/2009 - Arrayit Corporation and The Parkinson's Institute Announce New Research Collaboration.

3/19/2009 - Arrayit Corporation Trading Under New Symbol “ARYC”.

1/15/2009 - Arrayit Extends Worldwide Licensing of Its Patented High-Throughput Genotyping Platform.

10/07/2008 - Arrayit - BSI Alliance Provides New Research Technology to Identify Disease Diagnostics.

2/25/2008 - Dr. Mark Schena Announced President of Arrayit, Now a Wholly Owned Subsidiary of Integrated Media Holdings.

2/07/2008 - Arrayit Corporation Announces Acquisition By Integrated Media Holdings, Inc.

2/05/2008 - Arrayit Corporation Completes Business Combination With Integrated Media Holdings, Inc.

 

Forward Looking Statements
Some information contained in or incorporated by reference into this website are “forward looking statements” within the meaning of the United States private securities litigation reform act of 1995. All forward-looking statements involve risks and uncertainties. In particular, any statements regarding pro-forma finances, future sales, results of operations, operating efficiencies and product expansion are subject to known and unknown risks, uncertainties and contingencies. Many of these risks, uncertainties and contingencies are beyond the control of the company and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. Accordingly, you should not place undue reliance on the forward-looking statements contained in this website. These forward-looking statements speak only as of the date on which the statements were made. In evaluating forward-looking statements, you should consider these risks and uncertainties.  The company does not assume any obligation to update any such forward-looking statements to reflect events or circumstances after the date of posting of this information.

 

Investor and Media Contact
Arrayit Corporation
408.744.1331
investorrelations@arrayit.com

 

 

Copyright 1993-2014 Arrayit Corporation. All rights reserved.